Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?
- 21 February 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Gastroenterology & Hepatology
- Vol. 33 (4), 583-588
- https://doi.org/10.1097/meg.0000000000002057
Abstract
Introduction and objectives Hepatocellular carcinoma (HCC) is the 6th cause of cancer and hepatitis C (HCV) and B (HBV) viruses are the most frequent risk factors for HCC. Patients coinfected with HCV or HBV and HIV present a faster progression to liver fibrosis and higher incidence of HCC. The aim of this study was to evaluate the survival and clinical outcomes of coinfected patients with HCC comparing with non-HIV patients. Methods We conducted a retrospective cohort study, including 267 HCC patients with HCV or HBV infection with or without HIV. The primary endpoint was overall survival. A Kaplan–Meier curve was presented to assess survival function. Clinical and radiologic variables, according to HIV status, were compared by logistic regression. Results Among 267 HCC patients, 25 (9.3%) were HIV-positive. In the coinfected group, patients were younger (49.8 vs 61.2 years, P < 0.001), cirrhosis was less predominant (88 vs 96.7%, P = 0.05), a smaller proportion received HCC treatment (60 vs 86.3%, P = 0.001) and the frequency of portal vein tumoral thrombosis was higher (32 vs 11.1%, P = 0.003). The overall mortality rate was higher in the HIV-positive group (92 vs 74.3%), independently of clinical and tumoral variables. Conclusion Coinfected patients with HCC presented higher mortality, tumor diagnosis in a younger age, less underlying cirrhosis and a higher frequency of tumoral thrombosis. Further studies are warranted to better understand the role of HIV in hepatocarcinogenesis, in order to improve the management of those patients, particularly regarding screening programs.This publication has 27 references indexed in Scilit:
- Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patientsDigestive and Liver Disease, 2013
- Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in SpainClinical Infectious Diseases, 2012
- Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat HardThe Oncologist, 2011
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort StudiesClinical Infectious Diseases, 2010
- Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysisWorld Journal of Gastroenterology, 2009
- Natural history of chronic hepatitis B in co-infected patientsJournal of Hepatology, 2006
- Natural history and predictors of disease severity in chronic hepatitis CJournal of Hepatology, 2006
- Management of hepatocellular carcinomaHepatology, 2005
- Hepatocellular carcinoma in HIV-infected patientsAIDS, 2004
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999